Zobrazeno 1 - 10
of 44
pro vyhledávání: '"L, van Haelst"'
Autor:
Judith N. ten Sande, Paul L. van Haelst, Tineke P. Willems, Pascal F.H.M. van Dessel, Wouter P. te Rijdt, Arthur A.M. Wilde, Maarten P. van den Berg, Dirk J. van Veldhuisen, J. Peter van Tintelen, Thomas M. Gorter, Ingrid A.W. van Rijsingen, Albert J. H. Suurmeijer, Rudolf A. de Boer, S. Matthijs Boekholdt, R. Nils Planken, Paul A. van der Zwaag
Publikováno v:
European heart journal cardiovascular Imaging, 20(1), 92-100. Oxford University Press
European Heart Journal-Cardiovascular Imaging, 20(1), 92-100. Oxford University Press
European Heart Journal-Cardiovascular Imaging, 20(1), 92-100. Oxford University Press
Aims: The p.Arg14del founder mutation in the gene encoding phospholamban (PLN) is associated with an increased risk of malignant ventricular arrhythmia (VA) and heart failure. It has been shown to lead to calcium overload, cardiomyocyte damage, and e
Autor:
R. A. De Boer, M. Metra, C. Shi, Martin M Dokter, H. H. Van Der Wal, J. Post, F. Zannad, Adriaan A. Voors, Chim C. Lang, F. van den Berg, John G.F. Cleland, P. L. van Haelst, Jourik A. Gietema, L. Huizinga, D. J. Van Veldhuisen, Kenneth Dickstein, Pietro Ameri, Nilesh J. Samani, Marco Canepa, Leong L. Ng, M. Vriesema, Herman H W Silljé, Stefan D. Anker
Publikováno v:
Journal of Internal Medicine
Journal of Internal Medicine, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
Journal of Internal Medicine, 288(2), 207-218. Wiley
Journal of Internal Medicine, Wiley, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
Journal of Internal Medicine, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
Journal of Internal Medicine, 288(2), 207-218. Wiley
Journal of Internal Medicine, Wiley, 2020, 288 (2), pp.207-218. ⟨10.1111/joim.13053⟩
International audience; Background: There is increasing recognition that heart failure (HF) and cancer are conditions with a number of shared characteristics.Objectives: To explore the association between tumour biomarkers and HF outcomes.Methods: In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f8f62717f9e72a22640ecd5cfe68797
http://hdl.handle.net/11567/1024218
http://hdl.handle.net/11567/1024218
Autor:
Ingrid A.W. van Rijsingen, Edgar T. Hoorntje, Yigal M. Pinto, Francesco Russo, Joeri A. Jansweijer, Alex V. Postma, Rudolf A. de Boer, Ronald H. Lekanne Deprez, Jan D. H. Jongbloed, Arthur A.M. Wilde, Elena Biagini, Paul L. van Haelst, Maarten P. van den Berg, Marieke Bronk, J. Peter van Tintelen, Simone de Haij, Jan van Wijngaarden, Karin Y. van Spaendonck-Zwarts, Karin Nieuwhof, Marcel M.A.M. Mannens
Publikováno v:
European Journal of Heart Failure. 19:512-521
Aims Truncating titin mutations (tTTN) occur in 25% of dilated cardiomyopathy (DCM) cases, but the phenotype and severity of disease they cause have not yet been systematically studied. We studied whether tTTN variants are associated with a clinicall
Autor:
Erwin Birnie, Paul L. van Haelst, Irene M. van Langen, Maarten P. van den Berg, Rudolf A. de Boer, J. Peter van Tintelen, Karin Nieuwhof
Publikováno v:
European Journal of Human Genetics, 25, 169-175. Nature Publishing Group
European journal of human genetics, 25(2), 169-175. Nature Publishing Group
European journal of human genetics, 25(2), 169-175. Nature Publishing Group
Increasing numbers of patient relatives at risk of developing dilated or hypertrophic cardiomyopathy (DCM/HCM) are being identified and followed up by cardiologists according to the ACC/ESC guidelines. However, given limited healthcare resources, goo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::152780396dedff42d1a6b111c6f812e6
https://europepmc.org/articles/PMC5255955/
https://europepmc.org/articles/PMC5255955/
Autor:
Joeri A, Jansweijer, Karin, Nieuwhof, Francesco, Russo, Edgar T, Hoorntje, Jan D H, Jongbloed, Ronald H, Lekanne Deprez, Alex V, Postma, Marieke, Bronk, Ingrid A W, van Rijsingen, Simone, de Haij, Elena, Biagini, Paul L, van Haelst, Jan, van Wijngaarden, Maarten P, van den Berg, Arthur A M, Wilde, Marcel M A M, Mannens, Rudolf A, de Boer, Karin Y, van Spaendonck-Zwarts, J Peter, van Tintelen, Yigal M, Pinto
Publikováno v:
European journal of heart failure. 19(4)
Truncating titin mutations (tTTN) occur in 25% of dilated cardiomyopathy (DCM) cases, but the phenotype and severity of disease they cause have not yet been systematically studied. We studied whether tTTN variants are associated with a clinically dis
Autor:
Guy Hoffmann, E. Van Cauter, Julien Mendlewicz, E. D. Weitzman, Marc L'Hermite, V. Weinberg, Myriam Kerkhofs, L. Van Haelst, Paul Linkowski, Jacqueline Golstein, Claude Robyn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfa2ead3921679e9b6169874e84fd727
https://doi.org/10.1159/000408006
https://doi.org/10.1159/000408006
Autor:
Jasper S. Wijpkema, Gerrit van der Steege, Pieter A. Doevendans, PS Monraats, J. Wouter Jukema, Johannes Waltenberger, Marcel Bruinenberg, Rob J. de Winter, René A. Tio, Aeilko H. Zwinderman, Felix Zijlstra, Paul L. van Haelst
Publikováno v:
Pharmacogenetics and genomics, 16(5), 331-337. Lippincott Williams and Wilkins
PHARMACOGENETICS AND GENOMICS, 16(5), 331-337. LIPPINCOTT WILLIAMS & WILKINS
PHARMACOGENETICS AND GENOMICS, 16(5), 331-337. LIPPINCOTT WILLIAMS & WILKINS
Objectives The renin-angiotensin system (RAS) is thought to play a major role in the pathophysiology of de-novo restenotic lesions and in-stent restenosis after percutaneous coronary intervention (PCI). Heme oxygenase-1 (HO-1), is thought to benefici
Autor:
Ad J. van Boven, Thijs W. M. Plokker, Harry J.G.M. Crijns, Stefan H. J. Monnink, Paul L. van Haelst, Nic J. G. M. Veeger, Erik S.G. Stroes, Wiek H. van Gilst, Andries J. Smit, René A. Tio
Publikováno v:
Journal of investigative medicine, 50(1), 19-24. Lippincott Williams and Wilkins
Background Endothelial dysfunction is useful in predicting future cardiovascular disease. At present several tests are available to test endothelial function: coronary diameter response to acetylcholine, forearm bloodflow (FBF) response to acetylchol
Autor:
Albert J. H. Suurmeijer, Gilles F. H. Diercks, Johan Brügemann, Paul L. van Haelst, Dirk J. van Veldhuisen
Publikováno v:
Cardiovascular Pathology, 15(4), 228-230. ELSEVIER SCIENCE INC
Giant cell myocarditis (GCM) is a serious condition that warrants immediate diagnosis and treatment. It often presents as rapidly progressive heart failure and/or malignant ventricular arrhythmias. Here, we describe a 34-year-old patient with myasthe
Publikováno v:
European journal of obstetrics gynecology and reproductive biology, 100(1), 105-107. ELSEVIER SCIENCE BV
The clinical course of a pregnant patient, who presented with progressive dyspnea and heart failure is described. Despite intensive care and resuscitative efforts to mother and child, both expired. The autopsy revealed giant cell myocarditis in the m